PROVIDER PROFILE · NPI 1063726966

Manish Zinzuvadia

PsychiatryNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

7,280

Beneficiaries

—

Total drug cost

$3.6M

Distinct drugs

Brand share

25.8%

Top prescribed drugs

Olanzapine639 claims

Risperidone571 claims

Quetiapine Fumarate485 claims

Clonazepam363 claims

Risperidone320 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$239K

Payment records

312

By payment type

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$187K

Consulting Fee$22K

Travel and Lodging$20K

Food and Beverage$10K

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history